En español

Menu

Publications

Quick Links

COVID-19 is an emerging, rapidly evolving situation.


Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources

NIDA Notes Articles: Medication Development

NIDA Notes Category Graphic

Serotonin Receptor Agonist Lorcaserin Reduces Relapse to Drug Use in Monkeys

March 2020
The serotonin 2C receptor agonist lorcaserin reduced reinstatement of drug-seeking behavior in response to heroin or cocaine in a nonhuman primate model of relapse.

NIDA Notes Category Graphic

Part 2: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

February 2020
Researchers move their monoclonal antibody (mAb) into clinical trials to see if it can be an effective treatment for methamphetamine use.

NIDA Notes Category Graphic

Part 1: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

January 2020
Researchers have created a monoclonal antibody (mAb) that is intended to interact with methamphetamine and decrease its ability to enter the brain.

NIDA Notes Category Graphic

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 4

May 2019
Dr. Linda Dwoskin wins a NIDA grant to continue her team's work to find a medication to treat methamphetamine addiction—but there's a string attached.

NIDA Notes Category Graphic

A Promising Alternative to Opioid Pain Medications

February 2019
An experimental compound with a dual action at two opioid receptors may provide powerful pain relief without many of opioids' harmful side effects. En Español

NIDA Notes Category Graphic

In Animals, Opioid Combination Shows Promise for Safer Pain Relief

June 2018
In rats, the combination treatment of oxycodone/nalfurafine had lower levels of abuse liability and produced less respiratory depression than oxycodone alone.

NIDA Notes Category Graphic

Novel Compound Alleviates Hard-to-Treat Pain in Mice

June 2018
A novel compound called GAT211 alleviates inflammatory and neuropathic pain in mice without producing tolerance or signs of abuse liability.

NIDA Notes Category Graphic

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

May 2018
Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first ever medication to treat methamphetamine addiction.

NIDA Notes Category Graphic

Promising Advances in the Search for Safer Opioids

February 2017
New studies show that two novel compounds powerfully suppressed animals’ pain responses, while producing little or none of the respiratory depression and liability for misuse and abuse associated with morphine and other typical opioids.

NIDA Notes Category Graphic

Quinine as a Tracer for Medication Adherence

September 2016
Patients who don’t take their medications as prescribed often put themselves at risk for problems including misdiagnoses, complications, and death. A study suggests that adding low doses of quinine to patients’ medications could provide an inexpensive, reliable, and safe method of monitoring whether patients are taking their medications as directed.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics